Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022497
Filing Date
2017-11-08
Accepted
2017-11-08 08:01:26
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gthx-10q_20170930.htm 10-Q 1616368
2 EX-10.1 gthx-ex101_200.htm EX-10.1 44613
3 EX-31.1 gthx-ex311_7.htm EX-31.1 15852
4 EX-31.2 gthx-ex312_6.htm EX-31.2 15543
5 EX-32.1 gthx-ex321_8.htm EX-32.1 7309
6 EX-32.2 gthx-ex322_9.htm EX-32.2 7298
  Complete submission text file 0001564590-17-022497.txt   5400853

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT gthx-20170930.xml EX-101.INS 1207807
8 XBRL TAXONOMY EXTENSION SCHEMA gthx-20170930.xsd EX-101.SCH 36508
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthx-20170930_cal.xml EX-101.CAL 26654
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthx-20170930_def.xml EX-101.DEF 124173
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20170930_lab.xml EX-101.LAB 258821
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20170930_pre.xml EX-101.PRE 204392
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

EIN.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 171185135
SIC: 2834 Pharmaceutical Preparations